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Abstract
The crosstalk between fibroblasts and keratinocytes is a vital component of the wound healing process, and involves
the activity of a number of growth factors and cytokines. In this work, we develop a mathematical model of this crosstalk
in order to elucidate the effects of these interactions on the regeneration of collagen in a wound that heals by second
intention. We consider the role of four components that strongly affect this process: transforming growth factor-,
platelet-derived growth factor, interleukin-1 and keratinocyte growth factor. The impact of this network of interactions
on the degradation of an initial fibrin clot, as well as its subsequent replacement by a matrix that is mainly comprised of
collagen, is described through an eight-component system of nonlinear partial differential equations. Numerical results,
obtained in a two-dimensional domain, highlight key aspects of this multifarious process such as reepithelialisation.
The model is shown to reproduce many of the important features of normal wound healing. In addition, we use the
model to simulate the treatment of two pathological cases: chronic hypoxia, which can lead to chronic wounds; and
prolonged inflammation, which has been shown to lead to hypertrophic scarring. We find that our model predictions are
qualitatively in agreement with previously reported observations, and provide an alternative pathway for gaining insight
into this complex biological process.
Keywords: mathematical biology; mathematical modelling; wound healing; fibroblast-keratinocyte crosstalk; prolonged
inflammation; chronic hypoxia
1 INTRODUCTION
Wound healing is a complex, finely balanced process and,
in the case of successful healing, is generally thought
to comprise four interconnected and overlapping stages:
haemostasis (clot formation), inflammation, proliferation
and remodelling [1]. The formation of an initial fibrin clot,
as well as its degradation and subsequent replacement with
a stronger, mature matrix that is mainly comprised of colla-
gen, occurs as a result of a series of interactions, involving
the activity of a number of cells, growth factors (GFs) and
cytokines [2, 3]. Two key cells involved in this process are
fibroblasts and keratinocytes [4], whose interaction, via a
paracrine loop [5], is essential to the outcome of success-
ful dermal remodelling [6] and reepithelialisation [7]. This
dermal-epidermal crosstalk is currently an active area of bi-
ological research (see Werner et al. [8] for a comprehensive
review). It is known that keratinocytes and fibroblasts coop-
eratively induce gel contraction in vitro [9]. More recently,
it was observed that keratinocytes can regulate the modula-
tion of fibroblasts into a phenotype that is more suited to the
remodelling, rather than the deposition, of the extracellu-
lar matrix (ECM) [6, 10], thus precipitating the subsequent
stage of wound healing. Disruptions to this process can
lead to serious pathologies such as hypertrophic scars [11],
keloid scars [12] and nonhealing wounds [13]. It is there-
fore of crucial importance to throw light on such networks.
As it is difficult to conduct in vivo investigations into these
processes in a non-invasive manner, realistic mathematical
models that are based on known cell behaviours provide a
useful framework for studying the wound healing process
and its dysregulation.
One of the earliest mathematical models of wound heal-
ing was developed by Sherratt and Murray [14], who used
two coupled reaction-diffusion equations to describe reep-
ithelialisation, as well as the dependence of the rate of
wound closure on the rate of cell proliferation and the mi-
gratory activity of the cells. Tranquillo and Murray [15]
developed a model for the closure of a dermal wound that
included the production of collagen by the fibroblasts and
the effects of cell traction on the rate of wound closure.
This model has provided the basis for most subsequent
mechanochemical models of dermal wound healing, includ-
ing those by Olsen et al. [16], Tranqui and Tracqui [17]
and Vermolen and Javierre [18]. Cruywagen and Murray
[19], developed a continuum mechanical model of the inter-
actions between the dermal-epidermal layers of a develop-
ing embryo, assuming that “signal morphogens” are emit-
ted in one layer and have their paracrine effect in the other.
Several models have also been developed to study the ac-
tions of GFs during the wound healing process, including
the effect of keratinocyte growth factor (KGF) signalling
on dermal-epidermal interactions [20] and the chemotactic
and mitotic effect of platelet-derived growth factor (PDGF)
on fibroblasts in dermal wound healing [21], while Mur-
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phy and coworkers [22, 23, 24] recently investigated the
effects of transforming growth factor- (TGF-) and ten-
sion on dermal wound closure. There have also been sev-
eral models that describe the laying down of collagen fibres
in a wound, including those by Dale et al. [25] and Dal-
lon et al. [26], who investigated the effect of TGF- on this
process, and more recently by Cumming et al. [27], who
used a hybrid multiscale discrete-continuum model. De-
spite these numerous advances, to our knowledge there are
no mathematical models of wound healing that consider the
fibroblast-keratinocyte crosstalk that we argue is central to
the wound healing process.
Figure 1: Taken with permission from [83] (Copyright c1999 Mas-
sachusetts Medical Society). Schematic of a wound near the end of the
inflammatory stage and the beginning of the proliferative stage. We ob-
serve that a “tongue” of epidermal cells extends into the wound area due
to the migration and proliferation of keratinocytes. The progression of this
tongue depends on the availability of a suitable substrate. Note that our
model includes interleukin-1, which is not illustrated in the figure. In the
model that we present in this work, the x-axis runs parallel to the surface
of the skin, while the y-axis is perpendicular to the surface.
In this work, we simulate the behaviour of a wound
which is not surgically closed and which therefore heals
by second intention (see Fig. 1). In Sec. 2, we develop a
mathematical model that describes a set of interactions be-
tween fibroblasts and keratinocytes that are vital to the pro-
liferative phase of healing, as well as several critical GFs
and cytokines that mediate this crosstalk. As illustrated in
Fig. 1, during this stage enzymes produced by fibroblast
cells degrade the initial fibrin clot and synthesise a collagen-
based ECM in its place [28], while keratinocyte cells mi-
grate across the wound surface leading to reepithelialisation
[7]. In Sec. 4, we show that our model captures essential
features of the normal healing process, and can be used to
describe abnormal wound healing pathologies. It is widely
accepted that persistent, chronic hypoxia inhibits healing
[29, 30], and is one of the most common causes of chronic
wounds [31] in which healing fails to produce anatomic and
functional integrity [32]. In addition to chronic hypoxia, we
consider the case of an excessively long inflammatory re-
sponse, following Murphy et al. [24]. We find that when
treatment is initiated within an appropriate time frame our
model predicts that a normal healing outcome is achievable
in each pathological case.
2 MATHEMATICAL MODEL
We model a wound of partial thickness in which both the
dermal and epidermal layers are damaged. We present
our model in terms of spatial variables (x; y) and use this
model to simulate wound healing in a two-dimensional (2-
D) domain. In particular we focus on the complex net-
work of interactions that comprise the crosstalk between
keratinocyte and fibroblast cells, whose densities we rep-
resent by k(x; y; t) and f(x; y; t), respectively. Follow-
ing the approach of Cumming et al. [27], we assume that
a fibrin clot containing platelets is formed during the ini-
tial haemostasis phase and, on being degraded by enzymes
produced by fibroblasts, is replaced with a matrix mainly
comprised of collagen that allows keratinocyte migration.
In order to describe this process, the matrix in our model is
represented by two species c(x; y; t) and (x; y; t), cor-
responding to the fibrin clot and ECM densities, respec-
tively. Wound healing involves the activity of a large num-
ber of GFs and cytokines (see Barrientos et al. [33] for a
recent review). We restrict our attention to the activity of
those species which strongly impact the proliferation and
migration of fibroblasts and keratinocytes, as well as the
degradation and renewal of the ECM. Specifically, we con-
sider the concentrations of interleukin-1, i(x; y; t), KGF,
G(x; y; t), PDGF, P (x; y; t), and TGF-, (x; y; t).
1
Figure 2: Schematic of the interactions between the components of the
model. The references for each arrow are listed in Table S1 of the Supple-
mentary Material.
In Fig. 2, we present a schematic of what we be-
lieve to be the most important interactions between these
eight species during the dermal wound healing process. In
this work, we develop a 2-D model of nonlinear reaction-
diffusion partial differential equations to describe these in-
teractions. We now discuss the biological phenomena that
underpin the form of the equations.
2.1 Keratinocytes
Reepithelialisation is driven by the proliferation and migra-
tion of keratinocytes. It has been observed that this migra-
tion is dependent on the presence of an appropriate prox-
imate substrate, such as the newly-formed collagen-based
matrix [34, 35], and is stimulated by both the presence of
mature collagen [36] and fibronectin (which is present in the
fibrin clot) [37]. We note that in several models of angio-
genesis (see for example, Pettet et al. [38]) it is assumed that
endothelial cells require an ECM in order to migrate into
the wound bed. In our model we assume that keratinocyte
migration is dependent on the densities of the fibrin clot
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and mature collagen. Due to the rapid degradation of fibrin,
this migration effectively occurs along the fibrin-collagen
interface. This is consistent with the observation that the
keratinocytes form an invasive “tongue” prior to reepithe-
lialisation, as shown in Fig. 1. The proliferation of ker-
atinocytes is upregulated by the presence of fibrin [39] as
well as mature collagen [40], and we model this using a lo-
gistic form with an intrinsic proliferation rate constant 1.
This proliferation is upregulated by the presence of KGF
[41, 42] and is downregulated by the presence of TGF-
[43], which we model using the coefficients 2 and 3, re-
spectively. Assuming that this species has a maximum den-
sity k and random motility coefficient Dk, the fibrin clot
has initial density c, and the density of mature collagen in
the healed state is , we thus have:
@k
@t
= r 
Dk c 
c 
r k

+
1 c  (1 + 2G) k
1 + 3 

1  kk

:
migration proliferation
(1)
2.2 Fibroblasts
The proliferation and migration of fibroblasts are critically
important to successful dermal wound healing, as they re-
place lost collagen [28]. It has been observed that there is
an increased migration of fibroblasts due to a chemotactic
response to both PDGF [21] as well as TGF- [44], and we
model this using terms with chemotactic coefficients fP
and f , respectively. We model the proliferation of fi-
broblasts using a logistic form with an intrinsic prolifera-
tion rate constant 4. Keratinocytes are observed to have a
complex effect on the behaviour of fibroblasts: while they
secrete interleukin-1, which upregulates fibroblast prolifer-
ation [45], they also physically control the growth of fibrob-
lasts by forming colonies [46]. We model these processes
using the coefficients 5 and 7, respectively. Fibroblast
proliferation is further upregulated by the presence of TGF-
 [47], which we model using the coefficient 6. Assum-
ing that this species has a maximum density f and random
motility coefficient Df , we obtain:
@f
@t
= Df r2 f  r  (fP f rP )  r  (f f r)
random motion chemotaxis via P chemotaxis via 
+4
(1 + 5 i) (1 + 6 )
1 + 7 k
f

1  ff

:
proliferation
(2)
2.3 Initial provisional matrix (fibrin clot)
The initial provisional matrix is degraded by enzymes
which are produced by a variety of cells, in particular, fi-
broblasts [48, 49]. As an approximation to this more com-
plicated process, we model the degradation of the provi-
sional matrix as being (linearly) dependent on the fibroblast
cell density at a rate characterised by the constant 8. We
thus have:
@c
@t
=  8 f c :
degradation
(3)
2.4 Extracellular Matrix
Fibroblasts produce collagen, the main component of the
new ECM [50]. We model this dependence in line with
Flegg et al. [51] and Tracqui et al. [52], where a kinetic
term proportional to the fibroblast population is utilised.
This production is dependent on the concentration of oxy-
gen [53]; however, to avoid further complexity, we assume
the dependence of collagen production on oxygen is incor-
porated into the coefficient 9. Interleukin-1 is known to
downregulate the production of collagen by fibroblasts [54]
and TGF- is known to upregulate this process [55]. We
model these processes using the coefficients 10 and 11,
respectively. As fibroblasts are known to degrade newly
synthesised collagen [56], following Dallon and coworkers
[26, 57] we assume that this process occurs at a rate, char-
acterised by the constant 12, proportional to the collagen
density. We thus have:
@
@t
= 9 f
1 + 10 
1 + 11 i
  12 f  :
synthesis degradation
(4)
2.5 Interleukin-1
An important cytokine in the wound healing process is
interleukin-1 [58], whose production by keratinocytes [59]
we model using a linear term with rate constant 13. Cy-
tokines and GFs tend to have a half life of the order of a few
minutes [60], and so this decay is assumed to decay linearly
with rate constant 14. Assuming this species diffuses at a
rate characterised by the constant Di, we thus have:
@i
@t
= Dir2 i + 13 k   14 i :
diffusion production decay
(5)
2.6 Keratinocyte growth factor
KGF is known to play an important role in epidermal wound
healing [61]. Its production by fibroblasts, which is upregu-
lated by the presence of interleukin-1 [41, 42], is modelled
using a nonlinear term with coefficients 15 and 16. The
decay of this species is assumed to be linear with rate con-
stant 17. Assuming this species diffuses at a rate charac-
terised by the constant DG, we thus have:
@G
@t
= DGr2G +15 f (1 + 16 i)  17G :
diffusion production decay
(6)
2.7 Platelet-derived growth factor
PDGF is produced by degranulating platelets present in the
initial fibrin clot [62]. The rate of production of PDGF de-
creases as the fibrin clot is degraded, and we model this
production using a term with rate constant 18. This GF
decays naturally at a rate characterised by the constant 19,
and is further removed by fibroblasts through endocytosis
[21] at a rate characterised by the constant 20. Assuming
this species diffuses at a rate characterised by DP , we thus
have:
@P
@t
= DP r2 P + 18 c   19 P   20 f P :
diffusion production decay degradation
(7)
2.8 Transforming growth factor-
The protein TGF- exists in a number of isoforms, each
of which has different biochemical activities [63]. In our
model, we consider the activity of the TGF-1, as it is the
most prevalent isoform in wounds [64] and its activity in the
formation of scars is known to be significant [65]. TGF-
is secreted in a latent form and is then converted to an ac-
tive form by enzymes [25] or by myofibroblasts [66]. For
this investigation, we assume that this conversion occurs
Modelling the wound healing process 4
rapidly and represent both active and latent forms of TGF-
 by a single species, . Fibroblasts are one of the main
sources of TGF- in wounds [47], and their production of
this growth factor is inhibited if TGF- is already present
[25]. We model this production using a saturation form,
in line with the work of Murphy et al. [23], with the con-
stant 21 characterising the rate of production by fibroblasts
and the constant 23 characterising the half-maximal rate of
production. It has been observed that this production by fi-
broblasts is downregulated by the presence of keratinocytes
[67] and we model this using a downregulatory coefficient
22. Modelling the decay of TGF- using a linear term
with rate constant 24 and assuming that it diffuses at a rate
characterised by the constant D , we thus have:
@
@t
= D r2  + 21 f 
(1 + 22 k) (1 + 23 )
  24  :
diffusion production decay
(8)
Para- Dimensional Dimens- Source
meter ionless
Lx 1:0 cm 1 tw
Ly 0:3 cm 1 tw
 0:8 tw
 0:2 tw
t 1 day 1 tw
f 10 1 g=cm3 1 [69], tw
k 10 3 g=cm3 1 tw
c 10 3 g=cm3 1 [72], tw
 10 3 g=cm3 1 [72], tw
i 1:39 10 7 g=cm3 1 [71], tw
G 5:38 10 8 g=cm3 1 [20], tw
P 4:78 10 8 g=cm3 1 [21], tw
 2:75 10 7 g=cm3 1 [84]
Dk 4:33 10 9 cm2=s *2:59 10 4 [20]
Df 1:7 10 10 cm2=s *1:02 10 5 [85]
Di 6:93 10 6 cm2=s *0:42 [71], tw
DG 9:5 10 6 cm2=s *0:57 [20]
DP 2:78 10 8 cm2=s *1:67 10 3 [21]
D 2:94 10 7 cm2=s *1:76 10 2 [23]
fP 5:53 10 17 g=(cm:s) *0:69 10 4 tw
f 3:18 10 16 g=(cm:s) *0:69 10 4 tw
1 14 tw
2 3:2 [73]
3 1 [74]
4 3:5 tw
5 1:5 [75], tw
6 7:27 106 cm3=g 2 [23], [86]
7 10 tw
8 0:6 [57]
9 0:64 [57]
10 7:27 106 cm3=g 2 [23], [87]
11 1 [54]
12 0:44 [57]
13 16:6 tw
14 1:92 10 4 s 1 16:6 [76], tw
15 1:2 tw
16 5 [73], tw
17 8:33 10 5 s 1 7:2 [73]
18 2:4 tw
19 2:78 10 5 s 1 2:4 [21]
20 0:555 cm
3=(g:s) 48 [21], tw
21 0:5 cm
3=(g:day) 0:05 [23], [77]
22 0:6 [67], tw
23 1:3 106 cm3=g 0:3575 [88]
24 0:354 day
 1 0:354 [84]
Table 1: Parameter values for the model. Here, tw represents parame-
ters estimated in this work. The dimensionless values of the diffusion and
chemotactic coefficients (marked with a *) are those along the x axis. The
corresponding values along the y-axis are obtained by multiplying these
terms by (Lx=Ly)2.
2.9 Geometry, initial and boundary conditions
We assume that (x; y) represents a plane perpendicular to
the surface of the skin, which includes both epidermal and
dermal regions. Note that in Fig. 1, the x-axis runs paral-
lel to the surface of the skin and the y-axis is perpendicu-
lar to the surface. As illustrated in the schematic diagram
Fig. S1 of the Supplementary Material, we model a wound
of depth Ly and length 2Lx, with symmetry around x = 0
and where y = 0 represents the lower edge of the wound.
We assume that x = Lx represents the interface where the
wound meets healthy tissue and that  Ly < y < Ly rep-
resents the epidermal region. For our chosen values of Lx,
Ly and  (see Table 1), this assumption corresponds to the
physical extent of the human epidermis. Our computational
domain also contains some of the surrounding unwounded
tissue, and extends to the region   Ly < y < Ly ,
0 < x < (1 + )Lx.
We assume that keratinocytes are initially present in
the epidermal region outside the wounded area, x  Lx,
y   Ly , while fibroblasts and the ECM are present in
the region y < 0 as well as the dermal region outside
the wounded area, x  Lx, y   Ly. In our model,
interleukin-1 and KGF are produced by keratinocytes and
fibroblasts, respectively, and so we assume that they are
initially absent in the wounded area and present outside.
As PDGF and TGF- are produced by macrophages and
platelets present in the fibrin clot [62], we assume that they
are initially present in the wounded area and absent outside.
For the GFs, we use no-flux boundary conditions along each
boundary, while for the keratinocytes and fibroblasts, we
use no-flux boundary conditions along x = 0 and y = Ly
and Dirichlet boundary conditions along x = (1 + )Lx
and y =   Ly . These initial and boundary conditions are
simulated using steep tanh functions and are detailed in the
Supplementary Material. We now present a set of numeri-
cal results obtained using this model that describe different
wound healing outcomes. We include three movies in the
Supplementary Material that show the evolving densities of
keratinocytes over the entire domain for each outcome, il-
lustrating the development of the invasive “tongue” and the
subsequent migration of these cells across the wound.
3 MATERIALS AND METHODS
The model equations were non-dimensionalised (this is de-
tailed in the Supplementary Material) and numerical results
were obtained by integrating the resulting system using the
NAG subroutine D03RAF [68] for different choices of the
dimensionless parameters over a 2-D domain, with 121x121
grid points. A schematic of our non-dimensionalised model
is shown in Fig. S2 of the Supplementary Material. The
dimensional and dimensionless values for the parameters of
our model are listed in Table 1. While our model is intended
to be a caricature of the network of interactions that com-
prise the fibroblast-keratinocyte crosstalk, we have as far as
possible used parameter values that correspond to reported
experimental data. We now discuss how these parameters
were determined.
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3.1 Scaling, Diffusion and Random Motility Coeffi-
cients
The carrying capacity of fibroblast cells is roughly 106
ml 1 [69], while the volume of each cell, which weighs
the same as water, is around 10 7 cm3 [16]. We thus take
f = 10 1 g.cm 3. Noting that the molecular weight of
KGF is around 27 kDa [70], and taking the value for the
KGF concentration from Wearing and Sherratt [20], we
have G = 5:3810 8g.cm 3. Assuming that the density of
PDGF is the same as that of KGF and noting that the molec-
ular weight of PDGF is around 24 kDa [21] we take P =
4:78  10 8g.cm 3. The molecular weight of interleukin-
1 was found to be in the range 12   70 kDa [71], and for
our simulations we consider the higher value 70 kDa. As-
suming that the density of interleukin-1 is also the same as
that of KGF we take i = 1:39  10 7g.cm 3. We assume
that the densities of the ECM and the fibrin clot are compa-
rable and take both c and  to be 10 3g.cm 3, which lies
within the range of values previously used in simulations
by Namy et al. [72]. We also assume that the density of the
epidermal layer is similar to that of the dermal layer, and
take k to be 10 3g.cm 3. Using our assumed value for the
molecular weight of interleukin-1, we estimate the random
motility coefficient by considering the molecular weight,
m, and random motility coefficient, D, for another chemi-
cal usingD0  D (m=m0)1=3. Following [20], we consider
the species N-formyl-methionyl-leucyl-phenylalanine, for
whichD = 7:310 6cm2.s 1 andm = 60 kDa. We there-
fore obtain the estimateDi = 6:9310 6 cm2.s 1. Finally,
we assume that the dimensional values of the chemotactic
coefficients fP and f are 5:5310 17 g.cm 1.s 1 and
3:18 10 16 g.cm 1.s 1, respectively.
3.2 Reaction Kinetic Coefficients
For our simulations, we assume that the intrinsic growth
rate constants 1 and 4 have the dimensionless values
1 = 14 and 4 = 3:5, such that the wound closes within
3 weeks. It is known that KGF stimulates a 4.2-fold rise
in keratinocyte proliferation [73]; the proliferation of ker-
atinocytes will halve under the influence of TGF- [74];
interleukin-1 stimulates a 2.5-fold rise in fibroblast prolif-
eration [75], downregulates the production of collagen by
fibroblasts by 50% [54] and increases the production of
KGF by fibroblasts by a factor of 6 [73]; and the pres-
ence of keratinocytes decreases the production of TGF-
by a factor of 1.6 [67]. We thus set the dimensionless val-
ues 2 = 3:2, 3 = 1, 5 = 1:5, 11 = 1, 16 = 5
and 22 = 0:6. We set the dimensionless value 7 = 10
to ensure that keratinocytes sufficiently restrict the prolif-
eration of fibroblasts. The half-life of interleukin-1 mRNA
was found to be in the range 60–90min [76]. For our sim-
ulations, we use the upper limit and take the dimensional
value 14 = 1:92  10 4s 1. The dimensionless values
of 13 = 16:6, 15 = 1:2 are chosen such that we obtain
the steady state i = G = 1 inside the wound, while the
dimensionless value of 18 = 2:4 is chosen such that there
is a balance in the production and decay of PDGF in the
absence of fibroblasts. For the degradation of PDGF by en-
zymes produced by fibroblasts, we use the upper limit of
the range of values estimated by Haugh [21], and take the
dimensional value 20 = 5:55  10 1g 1.cm3.s 1. Fi-
nally, in the model by Murphy et al. [23], the rate of TGF-
 synthesis by fibroblasts is estimated to be 0:125  10 6
ng/(cell.day). This value was deduced from experiments by
Wang et al. [77], where the maximum dilution of TGF-
was 2:5ng.ml 1. Thus, we take the rate constant of TGF-
 production for a given density, f , of fibroblasts to be
21 = 0:5 g 1.cm3.day 1. The values of the parameters
6, 8, 9, 10, 12, 17, 19, 23 and 24 were taken di-
rectly from the corresponding references listed in Table 1.
4 RESULTS
4.1 Normal wound healing
We simulate the normal healing case using the parame-
ter values listed in Table 1. Fig. 3[top] shows how ker-
atinocytes migrate into the wound bed at the interface be-
tween the intact ECM and the fibrin clot, reproducing the
invasive “tongue” seen in Fig. 1. These cells subsequently
migrate across the wound site, leading to reepithelialisation,
as seen in Fig. 3[middle;bottom]. Although not shown here,
we also find that fibroblasts migrate over the entire domain,
completely degrading the fibrin clot and synthesising ma-
ture collagen in the process. The large initial concentra-
tion of TGF- in the wound is found to result in the pro-
duction of an excessive amount of collagen by fibroblasts;
however, the rapid drop in TGF- concentration, coupled
with increasing levels of interleukin-1 quickly downregu-
lates this production, and the ECM density approaches its
pre-wounded value. We now consider two pathologies that
can arise due to a disruption to the wound healing process.
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Figure 3: Numerical results for the non-dimensionalised system in the
case of normal wound healing for the choice of parameters listed in Ta-
ble 1. The spatial distribution of keratinocytes is shown at t=8.33 days
post-injury [top]. We observe that keratinocytes have migrated into the
wound space, reproducing the invasive “tongue” observed in Fig. 1. Fur-
ther, the distributions of keratinocytes [middle] and ECM [bottom] for the
same parameter values at t=18.5 days post-injury are shown. For this later
time, keratinocytes are mainly confined to the upper (epidermal) region
of the wound, resulting in an increased concentration of interleukin-1 and
consequently a reduced amount of ECM in this region. These results are
consistent with the expected behaviour of normal wounds, in which col-
lagen is deposited in the dermal regions by fibroblasts, and the previously
Modelling the wound healing process 6
discussed experimental observation that keratinocytes prevent the excess
production of collagen [6, 10].
4.2 Prolonged inflammation
First, we consider the case of an excessively long inflamma-
tory response. Murphy et al. [24] noted that poorly regu-
lated inflammatory mediators can lead to pathological scar-
ring and simulated this case by decreasing the decay rate
of TGF-. Such an assumption is justified by the observa-
tion that prolonged inflammation results in reduced levels
of neutrophils, which in turn negatively affects the ability
of chemoattractants to dissipate [78]. Thus, we follow the
approach used by Murphy et al. [24] and model this case
by decreasing the value of the parameter that characterises
the decay of TGF-, 24, by a factor of 10. We find that al-
though keratinocytes quickly migrate across the domain to
reepithelialise the wound (see Fig. 4[top]), the ECM levels
in this case are significantly increased.
The average ECM density (relative to normal) is calcu-
lated by averaging the net ECM density in the wound bed
at each timestep over the total number of grid points in this
region. A smooth function is then obtained using spline in-
terpolation, and this is then divided by the corresponding
function obtained for the normal case. Fig. 5 shows that the
ECM levels in the prolonged inflammation case, shown as a
thick red curve, are consistently much higher than normal.
This arises due to the prolonged presence of TGF- in the
wound (prolonged inflammation), which stimulates fibrob-
lasts to produce an excessive amount of collagen, and often
leads to hypertrophic scarring.
0
0.4
0.8
0 0.2 0.4 0.6 0.8 1
0.2
0.6
1
x
y
0
0.4
0.8
0 0.2 0.4 0.6 0.8 1
0.2
0.6
1
x
y
Figure 4: Spatial distributions of keratinocytes for the non-
dimensionalised system at t=18.5 days post-injury in the case of prolonged
inflammation [top] and chronic hypoxia [bottom]. For the case of pro-
longed inflammation, we use 24 = 0:0354 (corresponding to a decrease
in the decay rate of ), while for the case of chronic hypoxia, we use the
values 4 = 1:75, 9 = 0:432 and 21 = 0:016 (corresponding to a
decrease in the proliferation rate of f and the production rates of  and ,
respectively). We find that the wound takes far longer to reepithelialise in
the case of chronic hypoxia than in the case of prolonged inflammation.
4.3 Chronic hypoxia
We consider the case of chronic wound hypoxia, where a
significantly reduced concentration of oxygen inhibits the
healing process [79]. Prolonged hypoxia is one of the most
common causes of chronic wounds [31], where healing fails
to produce anatomic and functional integrity [32]. Siddiqui
et al. [80] noted that fibroblast cells placed in chronically
low oxygen levels over 72 hours exhibited a 50% decrease
in population doublings, a 1.48-fold reduction in collagen
production and a 3.1-fold decrease in TGF- production
relative to a standard oxygen system. These observations
confirm the findings that chronic hypoxia reduces colla-
gen production and that fibroblast proliferation is greatly
inhibited in this case [81]. We investigate this situation by
changing the parameters 4, 9 and 21 by these experi-
mentally determined amounts. As seen in Fig. 4[bottom],
keratinocytes take much longer to migrate across the wound
in this case.
The rate of wound closure is estimated by considering
the extent of the non-epithelialised region in each case (see
Supplementary Material for further details). Fig. 6 shows
the wound takes much longer to heal than in the normal
case, which is in agreement with the conclusions of Ober-
ringer et al. [30]. Additionally, as seen in Fig. 5, our model
predicts that collagen is produced at a slower rate than in
the normal case.
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Figure 5: Average density of ECM (relative to normal) for different
pathologies up to t=25 days. The normal case is represented by a thin
black line, while the case of prolonged inflammation and chronic hypoxia
are represented by thick red and blue lines respectively. The thick dashed
lines represent the situations where a treatment is applied in each case at
t=2.5, 5, 10, 15 and 20 days. In the case of prolonged inflammation, we
observe that the ECM levels in the wound tend to a much higher value
than for the normal wound, corresponding to hypertrophic scarring. On
the other hand, in the case of chronic hypoxia, we observe that the ECM
levels are around 0.5 times the normal value, and this significantly inhibits
the rate of healing (see Fig. 6). When treatment is applied in each case, the
ECM levels eventually approach a value close to that obtained in normal
healing process.
4.4 Implementation of treatment
Finally, we simulate the application of a treatment for the
two pathologies under consideration. Prolonged inflamma-
tion can be treated by blocking the TGF- pathway, for
instance by suppressing the secretion of TGF- by fibrob-
lasts (see Murphy et al. [24] for a recent discussion). We
therefore model the treatment of prolonged inflammation
by returning the rate of TGF- decay to the corresponding
value for the normal healing case. We note that early treat-
ment can significantly impact the wound healing outcome.
From Fig. 5 we see that a treatment applied at early times
can cause the ECM density to quickly approach the corre-
sponding value for the normal case. Furthermore, Fig. 6
shows that a treatment applied at days 2.5 and 5 can cause
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the wound to reepithelialise at a rate closer to the normal
rate, while treatments applied after 12.5 days will not af-
fect this process. These findings are in agreement with the
results of Murphy et al. [24], who noted that a healing strat-
egy implemented after around two weeks is less effective in
preventing hypertrophic scarring than an early treatment.
Tissue oxygen levels can be increased by the use of hy-
perbaric oxygen therapy, an approach that has been used to
treat chronic hypoxia [13]. We simulate this treatment at
various times by returning the proliferation rate of fibrob-
lasts and the rates of production of collagen and TGF-
to the corresponding values for the normal healing case.
As seen in Fig. 5, we find that the application of a treat-
ment causes the ECM density to approach the correspond-
ing value for the normal case. Furthermore, Fig. 6 shows
that on applying treatment, the wound reepithelialises at a
rate closer to that of a normal wound.
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Figure 6: Percentage of wound extent for different pathologies up to
t=25 days. The normal case is represented by a thick black line, while
the case of prolonged inflammation and chronic hypoxia are represented
by thick red and blue lines respectively. The thick dashed lines repre-
sent the situations where a treatment is applied in each case at t=2.5, 5,
10, 15 and 20 days. We find that wound reepithelialises at a much faster
rate in the case of prolonged inflammation, although it leads to excessive
collagen production (see Fig. 5), while a chronic hypoxic wound takes a
much longer time to reepithelialise. When a treatment is applied in the
case of hypoxia, the wound reepithelialises at a rate closer to that of a nor-
mal wound. However, in the case of prolonged inflammation, the wound
closes by t=12.5 days, and so any treatment effected after this time does
not impact the reepithelialisation process.
5 DISCUSSION
Wound healing has been the subject of many mathemati-
cal investigations over the last two decades. These models
have tended to concentrate on either epidermal or dermal
wound healing; however, it is known that the crosstalk be-
tween epidermal cells (keratinocytes), and the primary cells
of the dermis, namely fibroblasts, is critical to successful
wound healing. The model we have developed here is more
general than earlier models, as it explicitly takes these in-
teractions into account. For the sake of simplicity, we as-
sume that the fibrin clot is present initially, and so we do not
model its formation, which occurs rapidly after wounding.
As human wounds (healing by second intention) generally
tend to heal by infilling rather than contraction, we do not
include mechanical effects in our modelling. We note, how-
ever, that mechanical phenomena may play a role in severe
hypertrophic scarring.
Our predictions, based on the numerical solutions of a
coupled system of governing reaction-advection-diffusion
partial differential equations, capture many key aspects of
the wound healing process. In addition to reproducing a
healing timeline, which includes the removal of a fibrin clot
and reepithelialisation, that is qualitatively similar to the
observed wound healing process, our model can simulate
healing pathologies. To this end, we provide two illustra-
tive examples of sub-optimal healing that lead to excessive
collagen production and to a delay in healing, respectively.
We simulate the case of an excessively long inflamma-
tory response by assuming that the decay rate of TGF- is
small. Our model predicts that this situation can give rise to
hypertrophic scarring via the excessive production of col-
lagen by fibroblasts, and that this outcome can be most ef-
fectively prevented by implementing a healing strategy ef-
fected within two weeks.
Sufficient local oxygen levels are required in order to
facilitate normal fibroblast proliferation and collagen pro-
duction [82], and TGF- production. We simulate hypoxic
conditions by changing the values of the parameters that
correspond to these processes from their level in the normal
healing situation by experimentally determined amounts.
The significant delay in healing that we observe in the case
of chronic hypoxia is also in agreement with the literature
[13, 30]. Our model predicts that hypoxic wounds can be
successfully treated with the application of supplemental
oxygen, which is consistent with recent reviews [13].
This model could be extended in ways that may bet-
ter allow us to capture the healing process. For instance,
the sharp profiles of keratinocytes (see, for example, Fig. 3)
arise due to the initial rectangular geometry, and more re-
alistic behaviour could be obtained by using initial condi-
tions that more closely represent the geometry of a dermal
wound. Additionally, in order to prevent potential scenar-
ios in which the wound cannot reepithelialise, the dynamic
generation of the fibrin clot could be incorporated into the
model. Future models of this process could also consider
the competition for space that occurs between fibroblasts,
keratinocytes and mature collagen, which we ignore in this
model to avoid increasing its complexity. While every at-
tempt has been made to obtain parameter values that are
in agreement with previous experimental results, several
parameters in our model have been estimated in order to
obtain appropriate steady states, and to qualitatively sim-
ulate observed healing behaviour. A detailed parameter
sensitivity analysis, while outside the scope of the current
work, will help to further validate this model. Although
we have not attempted to address the full complexity of the
fibroblast-keratinocyte crosstalk in this work, we find that
our model captures the significant consequences of this crit-
ical biological process.
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